Paul A. Pham, Pharm.D., John G. Bartlett, M.D.
- Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other anti-fungal therapy.
- Esophageal candidiasis (authors’ opinion: would reserve caspofungin for azole-resistant cases).
- Empiric treatment of presumed fungal infections in febrile neutropenic patients.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2023 Unbound Medicine, Inc. All rights reserved